Incorporating a vascular term into a reference region model for the analysis of DCE-MRI data: A simulation study

Physics in Medicine and Biology

Volumn 53, Issue 10, 2008, Pages 2617-2631

  Faranesh, A Z ^a   Yankeelov, T E ^b,c  

^a STANFORD UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SIMULATION; ERROR ANALYSIS; PARAMETER ESTIMATION; PLASMA (HUMAN); TISSUE;

EXTRACELLULAR VOLUME; TEMPORAL RESOLUTION;

MAGNETIC RESONANCE IMAGING;

ARTICLE; CELL VOLUME; COMPARTMENT MODEL; COMPUTER ANALYSIS; COMPUTER SIMULATION; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REFERENCE REGION MODEL ANALYSIS; REFERENCE VALUE; TISSUE MICROARRAY; TISSUE OF INTEREST; VASCULAR DISEASE;

BLOOD VOLUME; CONTRAST MEDIA; KINETICS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; NEOPLASMS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 42649112050     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/10/012     Document Type: Article

References (40)

1. Buckley D L 2002 Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI Magn. Reson. Med. 47 601-6
2. Cha S, Johnson G, Wadghiri Y Z, Jin O, Babb J, Zagzag D and Turnbull D H 2003 Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology Magn. Reson. Med. 49 848-55
3. Chen W, Giger M L, Bick U and Newstead G M 2006 Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI Med. Phys. 33 2878-87
4. Eliat P P-A D 2004 Magnetic resonance imaging contrast-enhanced relaxometry of breast tumors: an MRI multicenter investigation concerning 100 patients Magn. Reson. Imaging 22 475-81
5. Evelhoch J L 1999 Key factors in the acquisition of contrast kinetic data for oncology J. Magn. Reson. Imaging 10 254-9
6. Faranesh A Z, Kraitchman D L and McVeigh E R 2006 Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent Magn. Reson. Med. 55 1114-23
7. Fournier L S, Novikov V, Lucidi V, Fu Y, Miller T, Floyd E, Shames D M and Brasch R C 2007 MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats Radiology 243 105-11
8. Furman-Haran E E S 2005 Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions Cancer 104 708-18
9. Goto M, Ito H, Akazawa K, Kubota T, Kizu O, Yamada K and Nishimura T 2007 Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features J. Magn. Reson. Imaging 25 104-12
10. Harrer J U, Parker G J, Haroon H A, Buckley D L, Embelton K, Roberts C, Baleriaux D and Jackson A 2004 Comparative study of methods for determining vascular permeability and blood volume in human gliomas J. Magn. Reson. Imaging 20 748-57
11. Henderson E, Rutt B K and Lee T Y 1998 Temporal sampling requirements for the tracer kinetics modeling of breast disease Magn. Reson. Imaging 16 1057-73
12. Henderson E, Sykes J, Drost D, Weinmann H J, Rutt B K and Lee T Y 2000 Simultaneous MRI measurement of blood, flow blood volume, and capillary permeability in mammary tumors using two different contrast agents J. Magn. Reson. Imaging 12 991-1003
13. Jain R K 1988 Determinants of tumor blood flow: a review Cancer research 48 2641-58
14. Kety S S 1951 The theory and applications of the exchange of inert gas at the lungs and tissues Pharmacol. Rev. 3 1-41
15. Kiessling F, Morgenstern B and Zhang C 2007 Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging Curr. Med. Chem. 14 77-91
16. Kono R, Fujimoto K, Terasaki H, Muller N L, Kato S, Sadohara J, Hayabuchi N and Takamori S 2007 Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions Am. J. Roentgenol. 188 26-36
17. Kovar D A, Lewis M and Karczmar G S 1998 A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues J. Magn. Reson. Imaging 8 1126-34
18. Kratz A and Lewandrowski K B 1998 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values N. Engl. J. Med. 339
19. Kuwatsuru R, Shames D M, Muhler A, Mintorovitch J, Vexler V, Mann J S, Cohn F, Price D, Huberty J and Brasch R C 1993 Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging Magn. Reson. Med. 30 76-81
20. Lankester K J, Maxwell R J, Pedley R B, Dearling J L, Qureshi U A, El Emir E, Hill S A and Tozer G M 2007 Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down Int. J. Oncol. 30 453-60
21. Larsson H B, Stubgaard M, Frederiksen J L, Jensen M, Henriksen O and Paulson O B 1990 Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors Magn. Reson. Med. 16 117-31
22. Lenth R V 2006 Java Applets for Power and Sample Size [Computer software] Retrieved 14 September 2007 from http://www.stat.uiowa.edu/∼rlenth/Power
23. Lopata R G 2007 On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging Magn. Reson. Med. 58 425-9
24. Misselwitz B, Schmitt-Willich H, Ebert W, Frenzel T and Weinmann H J 2001 Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent MAGMA 12 128-34
25. Montemurro F, Martincich L, Sarotto I, Bertotto I, Ponzone R, Cellini L, Redana S, Sismondi P, Aglietta M and Regge D 2007 Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer Eur. Radiol. 17 1490-7
26. Murase K 2004 Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging Magn. Reson. Med. 51 858-62
27. Nakamura K et al 2006 KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties Cancer Res. 66 9134-42
28. Ogan M D, Schmiedl U, Moseley M E, Grodd W, Paajanen H and Brasch R C 1987 Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization Invest. Radiol. 22 665-71
29. Parker G J, Roberts C, Macdonald A, Buonaccorsi G A, Cheung S, Buckley D L, Jackson A, Watson Y, Davies K and Jayson G C 2006 Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI Magn. Reson. Med. 56 993-1000
30. Provenzale J M, York G, Moya M G, Parks L, Choma M, Kealey S, Cole P and Serajuddin H 2006 Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms Am. J. Roentgenol. 187 1036-42
31. Su M Y et al 2003 Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer J. Magn. Reson. Imaging 18 467-77
32. Tofts P S 1997 Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J. Magn. Reson. Imaging 7 91-101
33. Tofts P S and Kermode A G 1991 Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1. fundamental concepts Magn. Reson. Med. 17 357-67
34. Tofts P S et al 1999 Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J. Magn. Reson. Imaging 10 223-32
35. Turetschek K, Preda A, Novikov V, Brasch R C, Weinmann H J, Wunderbaldinger P and Roberts T P 2004 Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights J. Magn. Reson. Imaging 20 138-44
36. Wilmes L J et al 2007 AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging Magn. Reson. Imaging 25 319-27
37. Yang C, Karczmar G S, Medved M and Stadler W M 2004 Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations Magn. Reson. Med. 52 1110-7
38. Yankeelov T E and Gore J C 2007 Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples Curr. Med. Imaging Rev. 3 91-107
39. Yankeelov T E, Luci J J, Lepage M, Li R, Debusk L, Lin P C, Price R R and Gore J C 2005 Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model Magn. Reson. Imaging 23 519-29
40. Zahra M A, Hollingsworth K G, Sala E, Lomas D J and Tan L T 2007 Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy Lancet Oncol. 8 63-74